Connect with us

Technology

GRAND CANYON EDUCATION, INC. REPORTS FOURTH QUARTER 2023 RESULTS

Published

on

PHOENIX, Feb. 13, 2024 /PRNewswire/ — Grand Canyon Education, Inc. (NASDAQ: LOPE), (“GCE” or the “Company”), is a publicly traded education services company that currently provides services to 25 university partners.  GCE provides a full array of support services in the post-secondary education sector and has developed significant technological solutions, infrastructure and operational processes to provide superior services in these areas on a large scale.  GCE today announced financial results for the quarter ended December 31, 2023. 

For the three months ended December 31, 2023:

Service revenue for the three months ended December 31, 2023 was $278.3 million, an increase of $19.6 million, or 7.6%, as compared to service revenue of $258.7 million for the three months ended December 31, 2022. The increase year over year in service revenue was primarily due to an increase in GCU enrollments to 117,279 at December 31, 2023, an increase of 8.0% over enrollments at December 31, 2022 and an increase in revenue per student year over year. The increase in revenue per student between years is primarily due to the service revenue impact of the increased room, board and other ancillary revenues at GCU in the fourth quarter of 2023 as compared to the prior year period. In addition, service revenue per student for Accelerated Bachelor of Science in Nursing students at off-campus classroom and laboratory sites generates a significantly higher revenue per student than we earn under our agreement with GCU, as these agreements generally provide us with a higher revenue share percentage, the partners have higher tuition rates than GCU and the majority of their students take more credits on average per semester. The increase in revenue per student in the three months ended December 31, 2023 was negatively impacted by the timing of the Fall semester for the ground traditional campus. The Fall semester started one day earlier in 2023 than in 2022, which had the effect of shifting $1.2 million in service revenue from the fourth quarter of 2023 to the third quarter of 2023 in comparison to the prior year.Partner enrollments totaled 121,250 at December 31, 2023 as compared to 112,955 at December 31, 2022. University partner enrollments at our off-campus classroom and laboratory sites were 4,481, a decrease of 3.3% over enrollments at December 31, 2022, which includes 510 and 320 GCU students at December 31, 2023 and 2022, respectively. We opened six new off-campus classroom and laboratory sites in the year ended December 31, 2022 and five sites in the year ended December 31, 2023 increasing the total number of these sites to 40 at December 31, 2023. Enrollments for GCU ground students were 25,209 at December 31, 2023 up from 24,943 at December 31, 2022. GCU online enrollments were 92,070 at December 31, 2023, up from 83,696 at December 31, 2022, an increase of 10.0% between years.Operating income for the three months ended December 31, 2023 was $97.8 million, an increase of $7.1 million as compared to $90.7 million for the same period in 2022. The operating margin for each of the three months ended December 31, 2023 and 2022 was 35.1%. The fourth quarter operating margin was negatively impacted on a year over year basis by the timing difference between years in the start of the Fall semester for GCU’s ground traditional campus.Income tax expense for the three months ended December 31, 2023 was $20.1 million, a decrease of $0.9 million, or 4.4%, as compared to income tax expense of $21.0 million for the three months ended December 31, 2022. Our effective tax rate was 19.9% during the fourth quarter of 2023 compared to 22.8% during the fourth quarter of 2022. The decrease in our effective tax rate between periods was primarily driven by other discrete tax items recorded in the respective periods.Net income increased 13.6% to $80.7 million for the fourth quarter of 2023, compared to $71.0 million for the same period in 2022. As adjusted net income was $82.5 million and $72.7 million for the fourth quarters of 2023 and 2022, respectively.Diluted net income per share was $2.71 and $2.30 for the fourth quarters of 2023 and 2022, respectively. As adjusted diluted net income per share was $2.77 and $2.36 for the fourth quarters of 2023 and 2022, respectively.Adjusted EBITDA increased 8.5% to $110.9 million for the fourth quarter of 2023, compared to $102.2 million for the same period in 2022.

For the year ended December 31, 2023:

Service revenue for the year ended December 31, 2023 was $960.9 million, an increase of $49.6 million, or 5.4%, as compared to service revenue of $911.3 million for the year ended December 31, 2022. The increase year over year in service revenue was primarily due to an increase in GCU enrollments to 117,279 at December 31, 2023, an increase of 8.0% over enrollments at December 31, 2022.Operating income for the year ended December 31, 2023 was $249.3 million, an increase of $11.8 million as compared to $237.5 million for the same period in 2022. The operating margin for the year ended December 31, 2023 was 25.9%, compared to 26.1% for the same period in 2022.Income tax expense for the year ended December 31, 2023 was $54.7 million, a decrease of $0.7 million, or 1.4%, as compared to income tax expense of $55.4 million for the year ended December 31, 2022. Our effective tax rate was 21.1% during the year ended December 31, 2023 compared to 23.1% during the year ended December 31, 2022. The decrease in our effective tax rate between periods is attributable to other discrete tax items recorded in the respective periods and higher excess tax benefits of $0.9 million compared to excess tax benefits of $0.1 million for the year ended December 31, 2022, partially offset by a lower contribution in lieu of state income taxes of $3.5 million in 2023 compared to $5.0 million in 2022.Net income increased 11.0% to $205.0 million for the year ended December 31, 2023, compared to $184.7 million for the same period in 2022. As adjusted net income was $212.2 million and $192.1 million for the years ended December 31, 2023 and 2022, respectively.Diluted net income per share was $6.80 and $5.73 for the years ended December 31, 2023 and 2022, respectively. As adjusted diluted net income per share was $7.04 and $5.96 for the years ended December 31, 2023 and 2022, respectively.Adjusted EBITDA increased 3.8% to $302.3 million for the year ended December 31, 2023, compared to $291.3 million for the same period in 2022.

Liquidity and Capital Resources

Our liquidity position, as measured by cash and cash equivalents and investments increased by $62.8 million between December 31, 2022 and December 31, 2023, which was largely attributable to cash flows from operations exceeding share repurchases, investment purchases, net of proceeds and capital expenditures during the year ended December 31, 2023.  Our unrestricted cash and cash equivalents and investments were $244.5 million and $181.7 million at December 31, 2023 and December 31, 2022, respectively.

2024 Outlook

Q1 2024:

Service revenue of between $271.5 million and $273.0 million;Operating margin of between 29.8% and 30.0%;Effective tax rate of 23.4%;Diluted EPS of between $2.15 and $2.18; and29.7 million diluted shares.

The diluted EPS guidance includes non-cash amortization of intangible assets net of taxes of $1.6 million, which equates to a $0.05 impact on diluted EPS. Thus, as adjusted, Non-GAAP diluted income per share of between $2.20 and $2.23

Q2 2024:

Service revenue of between $221.0 million and $224.0 million;Operating margin of between 16.1% and 17.0%;Effective tax rate of 24.9%;Diluted EPS of between $0.98 and $1.04; and29.4 million diluted shares.

The diluted EPS guidance includes non-cash amortization of intangible assets net of taxes of $1.6 million, which equates to a $0.05 impact on diluted EPS. Thus, as adjusted, Non-GAAP diluted income per share of between $1.03 and $1.09.

Q3 2024:

Service revenue of between $236.5 million and $244.0 million;Operating margin of between 20.4% and 22.2%;Effective tax rate of 24.9%;Diluted EPS of between $1.30 and $1.46; and29.1 million diluted shares.

The diluted EPS guidance includes non-cash amortization of intangible assets net of taxes of $1.6 million, which equates to a $0.05 impact on diluted EPS. Thus, as adjusted, Non-GAAP diluted income per share of between $1.35 and $1.51

Q4 2024:

Service revenue of between $287.0 million and $299.0 million;Operating margin of between 34.9% and 37.0%;Effective tax rate of 22.8%;Diluted EPS of between $2.75 and $3.03; and28.9 million diluted shares.

The diluted EPS guidance includes non-cash amortization of intangible assets net of taxes of $1.6 million, which equates to a $0.06 impact on diluted EPS. Thus, as adjusted, Non-GAAP diluted income per share of between $2.81 and $3.09

Full Year 2024:

Service revenue of between $1,016.0 million and $1,040.0 million;Operating margin of between 26.1% and 27.4%;Effective tax rate of 23.7%;Diluted EPS between $7.17 and $7.69; and29.3 million diluted shares.

The diluted EPS guidance includes non-cash amortization of intangible assets net of taxes of $6.5 million, which equates to a $0.22 impact on diluted EPS. Thus, as adjusted, Non-GAAP diluted income per share of between $7.39 and $7.91.

Forward-Looking Statements

This news release contains “forward-looking statements” which include information relating to future events, future financial performance, strategies expectations, competitive environment, regulation, and availability of resources.  These forward-looking statements include, without limitation, statements regarding: proposed new programs; whether regulatory, economic, or business developments or other matters may or may not have a material adverse effect on our financial position, results of operations, or liquidity; projections, predictions, expectations, estimates, and forecasts as to our business, financial and operating results, and future economic performance; and management’s goals and objectives and other similar expressions concerning matters that are not historical facts.  Words such as “may,” “should,” “could,” “would,” “predicts,” “potential,” “continue,” “expects,” “anticipates,” “future,” “intends,” “plans,” “believes,” “estimates” and similar expressions, the negative of these expressions, as well as statements in future tense, identify forward-looking statements.

Forward-looking statements should not be read as a guarantee of future performance or results and will not necessarily be accurate indications of the times at, or by, which such performance or results will be achieved.  Forward-looking statements are based on information available at the time those statements are made or management’s good faith belief as of that time with respect to future events and are subject to risks and uncertainties that could cause actual performance or results to differ materially from those expressed in or suggested by the forward-looking statements.  Important factors that could cause our actual performance or results to differ materially from those expressed in or suggested by the forward-looking statements include, but are not limited to: legal and regulatory actions taken against our university partners that impact their businesses and that directly or indirectly reduce the service revenue we can earn under our master services agreements; the occurrence of any event, change or other circumstance that could give rise to the termination of any of the key university partner agreements; our ability to properly manage risks and challenges associated with strategic initiatives, including potential acquisitions or divestitures of, or investments in, new businesses, acquisitions of new properties and new university partners, and expansion of services provided to our existing university partners; our failure to comply with the extensive regulatory framework applicable to us either directly as a third-party service provider or indirectly through our university partners, including Title IV of the Higher Education Act and the regulations thereunder, state laws and regulatory requirements, and accrediting commission requirements; the harm to our business, results of operations, and financial condition, and harm to our university partners resulting from epidemics, pandemics, or public health crises; the ability of our university partners’ students to obtain federal Title IV funds, state financial aid, and private financing; potential damage to our reputation or other adverse effects as a result of negative publicity in the media, in the industry or in connection with governmental reports or investigations or otherwise, affecting us or other companies in the education services sector; risks associated with changes in applicable federal and state laws and regulations and accrediting commission standards, including pending rulemaking by the United States Department of Education applicable to us directly or indirectly through our university partners; competition from other education service companies in our geographic region and market sector, including competition for students, qualified executives and other personnel; our expected tax payments and tax rate; our ability to hire and train new, and develop and train existing employees; the pace of growth of our university partners’ enrollment and its effect on the pace of our own growth; fluctuations in our revenues due to seasonality; our ability to, on behalf of our university partners, convert prospective students to enrolled students and to retain active students to graduation; our success in updating and expanding the content of existing programs and developing new programs in a cost-effective manner or on a timely basis for our university partners; risks associated with the competitive environment for marketing the programs of our university partners; failure on our part to keep up with advances in technology that could enhance the experience for our university partners’ students; our ability to manage future growth effectively; the impact of any natural disasters or public health emergencies; general adverse economic conditions or other developments that affect the job prospects of our university partners’ students; and other factors discussed in reports on file with the Securities and Exchange Commission, including as set forth in Part I, Item 1A of our Annual Report on Form 10-K for period ended December 31, 2023, as updated in our subsequent reports filed with the Securities and Exchange Commission on Form 10-Q or Form 8-K.

Forward-looking statements speak only as of the date the statements are made.  You should not put undue reliance on any forward-looking statements.  We assume no obligation to update forward-looking statements to reflect actual results, changes in assumptions, or changes in other factors affecting forward-looking information, except to the extent required by applicable securities laws.  If we do update one or more forward-looking statements, no inference should be drawn that we will make additional updates with respect to those or other forward-looking statements.

Conference Call

Grand Canyon Education, Inc. will discuss its fourth quarter 2023 results and full year 2024 outlook during a conference call scheduled for today, February 13, 2024 at 4:30 p.m. Eastern time (ET).  

Live Conference Dial-In:

Those interested in participating in the question-and-answer session should follow the conference dial-in instructions below.  Participants may register for the call here to receive the dial-in numbers and unique PIN to access the call seamlessly. Please dial in at least ten minutes prior to the start of the call.  Journalists are invited to listen only. 

Webcast and Replay:

Investors, journalists and the general public may access a live webcast of this event at: Q4 2023 Grand Canyon Education Inc. Earnings Conference Call. A webcast replay will be available approximately two hours following the conclusion of the call at the same link.

About Grand Canyon Education, Inc.

Grand Canyon Education, Inc. (“GCE”), incorporated in 2008, is a publicly traded education services company that currently provides services to 25 university partners.  GCE is uniquely positioned in the education services industry in that its leadership has over 30 years of proven expertise in providing a full array of support services in the post-secondary education sector and has developed significant technological solutions, infrastructure and operational processes to provide superior services in these areas on a large scale.  GCE provides services that support students, faculty and staff of partner institutions such as marketing, strategic enrollment management, counseling services, financial services, technology, technical support, compliance, human resources, classroom operations, content development, faculty recruitment and training, among others.  For more information about GCE visit the Company’s website at www.gce.com.

Grand Canyon Education, Inc., 2600 W. Camelback Road, Phoenix, AZ 85017, www.gce.com.

 

GRAND CANYON EDUCATION, INC.

Consolidated Income Statements

(Unaudited)

Three Months Ended

Year Ended

December 31, 

December 31, 

2023

2022

2023

2022

(In thousands, except per share data)

Service revenue

$

278,284

$

258,700

$

960,899

$

911,306

Costs and expenses:

Technology and academic services

39,227

38,357

154,870

150,493

Counseling services and support

82,754

72,540

302,319

273,313

Marketing and communication

46,003

44,853

202,800

196,090

General and administrative

10,397

10,168

43,235

45,491

Amortization of intangible assets

2,104

2,104

8,419

8,419

Total costs and expenses

180,485

168,022

711,643

673,806

Operating income

97,799

90,678

249,256

237,500

Interest expense

(6)

3

(33)

(2)

Investment interest and other

2,970

1,327

10,452

2,621

Income before income taxes

100,763

92,008

259,675

240,119

Income tax expense

20,054

20,981

54,690

55,444

Net income

$

80,709

$

71,027

$

204,985

$

184,675

Earnings per share:

Basic income per share

$

2.73

$

2.32

$

6.83

$

5.75

Diluted income per share

$

2.71

$

2.30

$

6.80

$

5.73

Basic weighted average shares outstanding

29,555

30,669

29,991

32,131

Diluted weighted average shares outstanding

29,761

30,835

30,147

32,237

 

GRAND CANYON EDUCATION, INC.

Consolidated Balance Sheets

As of December 31, 

As of December 31,

(In thousands, except par value)

2023

2022

ASSETS:

(Unaudited)

Current assets

Cash and cash equivalents

$

146,475

$

120,409

Investments

98,031

61,295

Accounts receivable, net

78,811

77,413

Income taxes receivable

1,316

2,788

Other current assets

12,889

11,368

Total current assets

337,522

273,273

Property and equipment, net

169,699

147,504

Right-of-use assets

92,454

72,719

Amortizable intangible assets, net

168,381

176,800

Goodwill

160,766

160,766

Other assets

1,641

1,687

Total assets

$

930,463

$

832,749

LIABILITIES AND STOCKHOLDERS’ EQUITY:

Current liabilities

Accounts payable

$

17,676

$

20,006

Accrued compensation and benefits

31,358

36,412

Accrued liabilities

26,725

22,473

Income taxes payable

10,250

12,167

Current portion of lease liability

11,024

8,648

Total current liabilities

97,033

99,706

Deferred income taxes, noncurrent

26,749

26,195

Other long-term liabilities

410

436

Lease liability, less current portion

88,257

68,793

Total liabilities

212,449

195,130

Commitments and contingencies

Stockholders’ equity

Preferred stock, $0.01 par value, 10,000 shares authorized; 0 shares issued and
outstanding at December 31, 2022 and December 31, 2022

Common stock, $0.01 par value, 100,000 shares authorized; 53,970 and 53,830 shares
issued and 29,953 and 31,058 shares outstanding at December 31, 2023 and December
31, 2022, respectively

540

538

Treasury stock, at cost, 24,017 and 22,772 shares of common stock at December 31, 2023
and December 31, 2022, respectively

(1,849,693)

(1,711,423)

Additional paid-in capital

322,512

309,310

Accumulated other comprehensive loss

(57)

(533)

Retained earnings

2,244,712

2,039,727

Total stockholders’ equity

718,014

637,619

Total liabilities and stockholders’ equity

$

930,463

$

832,749

 

GRAND CANYON EDUCATION, INC.

Consolidated Statements of Cash Flows

(Unaudited)

Year Ended

December 31, 

(In thousands)

2023

2022

Cash flows provided by operating activities:

Net income

$

204,985

$

184,675

Adjustments to reconcile net income to net cash provided by operating activities:

Share-based compensation

13,204

12,642

Depreciation and amortization

23,554

22,758

Amortization of intangible assets

8,419

8,419

Deferred income taxes

402

401

Other, including fixed asset disposals

(442)

853

Changes in assets and liabilities:

   Accounts receivable from university partners

(1,398)

(7,350)

   Other assets

(1,639)

(2,604)

   Right-of-use assets and lease liabilities

2,105

1,193

   Accounts payable

(3,109)

(3,894)

   Accrued liabilities

(1,974)

(1,023)

   Income taxes receivable/payable

(445)

4,759

   Deferred revenue

(10)

Net cash provided by operating activities

243,662

220,819

Cash flows used in investing activities:

Capital expenditures

(44,537)

(35,232)

Additions of amortizable content

(897)

(397)

Purchases of investments

(98,853)

(171,549)

Proceeds from sale or maturity of investments

63,815

110,039

Net cash used in investing activities

(80,472)

(97,139)

Cash flows used in financing activities:

Repurchase of common shares and shares withheld in lieu of income taxes

(137,124)

(604,212)

Net cash used in financing activities

(137,124)

(604,212)

Net increase (decrease) in cash and cash equivalents and restricted cash

26,066

(480,532)

Cash and cash equivalents and restricted cash, beginning of period

120,409

600,941

Cash and cash equivalents and restricted cash, end of period

$

146,475

$

120,409

Supplemental disclosure of cash flow information

Cash paid for interest

$

33

$

2

Cash paid for income taxes

$

59,026

$

48,573

Supplemental disclosure of non-cash investing and financing activities

Purchases of property and equipment included in accounts payable

$

1,909

$

1,131

ROU Asset and Liability recognition

$

19,735

$

15,067

Excise tax on treasury stock repurchases

$

1,146

$

 

GRAND CANYON EDUCATION, INC.

Adjusted EBITDA  (Non-GAAP Financial Measure)

Adjusted EBITDA is defined as net income plus interest expense, less interest income and other gain (loss) recognized on investments, plus income tax expense, and plus depreciation and amortization (EBITDA), as adjusted for (i)  contributions to private Arizona school tuition organizations in lieu of the payment of state income taxes; (ii) share-based compensation, and (iii) unusual charges or gains, such as litigation and regulatory reserves, impairment charges and asset write-offs, and exit or lease termination costs.  We present Adjusted EBITDA because we consider it to be an important supplemental measure of our operating performance.  We also make certain compensation decisions based, in part, on our operating performance, as measured by Adjusted EBITDA.  All of the adjustments made in our calculation of Adjusted EBITDA are adjustments to items that management does not consider to be reflective of our core operating performance.  Management considers our core operating performance to be that which can be affected by our managers in any particular period through their management of the resources that affect our underlying revenue and profit generating operations during that period and does not consider the items for which we make adjustments (as listed above) to be reflective of our core performance.

We believe Adjusted EBITDA allows us to compare our current operating results with corresponding historical periods and with the operational performance of other companies in our industry because it does not give effect to potential differences caused by variations in capital structures (affecting relative interest expense, including the impact of write-offs of deferred financing costs when companies refinance their indebtedness), tax positions (such as the impact on periods or companies of changes in effective tax rates or net operating losses), the book amortization of intangibles (affecting relative amortization expense), and other items that we do not consider reflective of underlying operating performance.  We also present Adjusted EBITDA because we believe it is frequently used by securities analysts, investors, and other interested parties as a measure of performance.

In evaluating Adjusted EBITDA, investors should be aware that in the future we may incur expenses similar to the adjustments described above.  Our presentation of Adjusted EBITDA should not be construed as an inference that our future results will be unaffected by expenses that are unusual, non-routine, or non-recurring.  Adjusted EBITDA has limitations as an analytical tool in that, among other things it does not reflect:

cash expenditures for capital expenditures or contractual commitments;changes in, or cash requirements for, our working capital requirements;interest expense, or the cash required to replace assets that are being depreciated or amortized; andthe impact on our reported results of earnings or charges resulting from the items for which we make adjustments to our EBITDA, as described above and set forth in the table below.

In addition, other companies, including other companies in our industry, may calculate these measures differently than we do, limiting the usefulness of Adjusted EBITDA as a comparative measure.  Because of these limitations, Adjusted EBITDA should not be considered as a substitute for net income, operating income, or any other performance measure derived in accordance with and reported under GAAP, or as an alternative to cash flow from operating activities or as a measure of our liquidity.  We compensate for these limitations by relying primarily on our GAAP results and only use Adjusted EBITDA as a supplemental performance measure.

The following table provides a reconciliation of net income to Adjusted EBITDA, which is a non-GAAP measure for the periods indicated:

Three Months Ended

Year Ended

December 31, 

December 31, 

2023

2022

2023

2022

(Unaudited, in thousands)

(Unaudited, in thousands)

Net income

$

80,709

$

71,027

$

204,985

$

184,675

Plus: interest expense

6

(3)

33

2

Less: investment interest and other

(2,970)

(1,327)

(10,452)

(2,621)

Plus: income tax expense

20,054

20,981

54,690

55,444

Plus: amortization of intangible assets

2,104

2,104

8,419

8,419

Plus: depreciation and amortization

6,560

5,735

23,554

22,758

EBITDA

106,463

98,517

281,229

268,677

Plus: contributions in lieu of state income taxes

3,500

5,000

Plus: loss on fixed asset disposal

166

94

741

1,249

Plus: litigation and regulatory reserves

1,057

452

3,628

3,768

Plus: share-based compensation

3,246

3,158

13,204

12,642

Adjusted EBITDA

$

110,932

$

102,221

$

302,302

$

291,336

Non-GAAP Net Income and Non-GAAP Diluted Income Per Share

The Company believes the presentation of non-GAAP net income and non-GAAP diluted income per share information that excludes amortization of intangible assets and loss on disposal of fixed assets allows investors to develop a more meaningful understanding of the Company’s performance over time.  Accordingly, for the three-months and years ended December 31, 2023 and 2022, the table below provides reconciliations of these non-GAAP items to GAAP net income and GAAP diluted income per share, respectively:

Three Months Ended

Year Ended

December 31, 

December 31, 

2023

2022

2023

2022

(Unaudited, in thousands except per share data)

GAAP Net income

$

80,709

$

71,027

$

204,985

$

184,675

Amortization of intangible assets

2,104

2,104

8,419

8,419

Loss on disposal of fixed assets

166

94

741

1,249

Income tax effects of adjustments(1)

(452)

(501)

(1,929)

(2,232)

As Adjusted, Non-GAAP Net income

$

82,527

$

72,724

$

212,216

$

192,111

GAAP Diluted income per share

$

2.71

$

2.30

$

6.80

$

5.73

Amortization of intangible assets (2)

0.06

0.06

0.22

0.20

Loss on disposal of fixed assets (3)

0.00

0.00

0.02

0.03

As Adjusted, Non-GAAP Diluted income per share

$

2.77

$

2.36

$

7.04

$

5.96

(1)

The income tax effects of adjustments are based on the effective income tax rate applicable to adjusted (non-GAAP) results. 

(2)

The amortization of acquired intangible assets per diluted share is net of an income tax benefit of $0.01 and $0.02 for the three months ended December 31, 2023 and 2022, respectively, and net of an income tax benefit of $0.06 for each of the years ended December 31, 2023 and 2022.

(3)

The loss on disposal of fixed assets per diluted share is net of an income tax benefit of $0.00 for each of the three months ended December 31, 2023 and 2022, and net of an income tax benefit of $0.01 and $0.01 for the years ended December 31, 2023 and 2022, respectively.

Investor Relations Contact:
Daniel E. Bachus
Chief Financial Officer
Grand Canyon Education, Inc.
602-639-6648
Dan.bachus@gce.com 

View original content:https://www.prnewswire.com/news-releases/grand-canyon-education-inc-reports-fourth-quarter-2023-results-302061042.html

SOURCE Grand Canyon Education

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Technology

BillionToOne Launches Unity Confirm™: A category-defining test that bridges the gap between screening and invasive diagnostics

Published

on

By

A breakthrough in prenatal care, Unity Confirm enables non-invasive confirmation for high-risk screening results through the capture of intact circulating fetal cells using BillionToOne’s Fetal Cell Capture™ Technology

MENLO PARK, Calif., May 1, 2026 /PRNewswire/ — For more than two decades, the ultimate quest for scientists and clinicians studying prenatal genetics was the capture of an intact fetal cell non-invasively so that its fetal DNA could be directly analyzed. While cell-free DNA has revolutionized prenatal genetics, it left an uncertainty—a gap between screening and invasive diagnostics, for patients who cannot, or choose not to, access invasive diagnostics. Today, BillionToOne, Inc. (Nasdaq: BLLN), a next-generation molecular diagnostics company with a mission to create powerful and accurate tests that are accessible to all, announced the launch of Unity Confirm™, a circulating fetal cell-based, non-invasive confirmation test, designed to address this need from a simple maternal blood draw.

Since its introduction in the early 2010s, non-invasive prenatal testing (NIPT) has become the standard of care for screening for fetal aneuploidies. However, when screening returns a high-risk result, clinical guidelines recommend diagnostic confirmation via chorionic villus sampling (CVS) or amniocentesis. These invasive procedures carry a small but real risk of pregnancy loss, and are increasingly difficult to access. The majority of patients decline, leaving clinicians and families without the information needed to guide next steps, and widening gaps in inequitable care.

While cell-based prenatal genetics has been studied since before the advent of cell-free DNA tests, the scientific barrier has long been the rarity and fragility of fetal cells in maternal circulation. Presenting at fewer than one cell per milliliter of blood and nearly indistinguishable from millions of surrounding maternal cells, intact circulating fetal cells have been too difficult to isolate in an accessible way for clinical use. The cell-based approaches were previously studied across multiple independent publications1 in more than 1,500 patients, consistently demonstrating that when a fetal cell is captured and sequenced, it provides an accurate result that has extremely high concordance with invasive diagnostic testing. However, these methodologies have stayed too academic, expensive, and inaccessible.

Unity Confirm addresses this directly. Available for all patients who use UNITY Aneuploidy for their front-line screen*, BillionToOne’s Fetal Cell Capture™ technology, a multi-step immunological enrichment and single cell isolation process, isolates intact circulating fetal cells, effectively providing 100% fetal fraction2, and performs whole genome sequencing on each individual cell. By analyzing the direct fetal cells rather than fragmentary cfDNA, similar to invasive procedures, Unity Confirm delivers rapid CVS-like insights3 non-invasively, from a single blood draw.

“For years, the idea of capturing whole fetal cells non-invasively was largely viewed as an elusive holy grail, something theoretically possible but practically out of reach,” said Oguzhan Atay, PhD, Co-founder and CEO of BillionToOne. “Unity Confirm is proof that it does not have to be. For the first time, a clinician can confirm a high-risk prenatal result non-invasively, with a level of accuracy the field has never before seen outside of an invasive procedure. For the first time, this technology is broadly accessible.”

“A high-risk NIPT result does not give you a diagnosis. It gives you a decision to make under enormous stress, often without enough information,” said Haywood Brown, MD, Chief Medical Officer, Prenatal, BillionToOne. “For too long, the options were limited: forgo confirmation, or undergo an invasive procedure with a small but real risk. What makes Unity Confirm truly different is not just the science; it is that this capability is now clinically accessible. That’s not an incremental improvement. That is a fundamentally different standard of care.”

In BillionToOne’s own clinical validation, Unity Confirm demonstrated 100% concordance with known fetal outcomes and invasive diagnostic results across 16 of 16 samples, including affected fetuses for common aneuploidies and 22q11.2 microdeletion. The clinical data supporting Unity Confirm will be presented at ACOG 2026 in Washington, D.C., presenting the science behind the technology to the broader OB/GYN community for the first time. Beginning on May 28, providers using Unity Aneuploidy™ Screen will have access to Unity Confirm following a high-risk result. To further validate performance at scale, BillionToOne is now enrolling in the largest prospective study of a fetal cell-based confirmation assay with invasive diagnostic outcomes, targeting enrollment of 1,000 patients and measuring concordance to invasive diagnostic testing.

*Unity Confirm is intended for patients who cannot, or choose not to, pursue invasive diagnostic testing following a high-risk Unity Aneuploidy Screen result before 16 weeks of gestation. Available for Trisomy 21 (Down syndrome), Trisomy 18, Trisomy 13, 22q11.2 microdeletion, XXY, XYY, and XXX aneuploidies. Requires Unity Aneuploidy Screen as the frontline screen for the pregnancy.

Sources

1Hatt, Lotte, et al. “A new marker set that identifies fetal cells in maternal circulation with high specificity.” Prenatal Diagnosis 34.11 (2014): 1066-1072.; Stampalija, T., et al. “Single-cell-based non-invasive screening for fetal pathogenic microimbalances using maternal blood: comparison with invasive prenatal diagnosis.” Ultrasound in Obstetrics & Gynecology (2026).; Weymaere, Jana, et al. “Enrichment of circulating trophoblasts from maternal blood using filtration-based Metacell® technology.” Plos one 17.7 (2022):e0271226.; Jeppesen, Line Dahl, et al. “Screening for Fetal Aneuploidy and Sex Chromosomal Anomalies in a Pregnant Woman with Mosaicism for Turner Syndrome—Applications and Advantages of Cell-Based NIPT.” Frontiers in Genetics 12 (2021): 741752.; Bellair, Michelle, et al. “Noninvasive single-cell-based prenatal genetic testing: A proof of concept clinical study.” Prenatal Diagnosis 44.3 (2024):304-316.; Chakchouk, Imen, and Ignatia B. Van den Veyver. “Whole-Genome Amplification on Single Circulating Trophoblast Cell.” Whole Genome Amplification: Methods and Protocols. New York, NY: Springer US, 2026. 11-23.; Zhuo, Xinming, et al. “Use of amplicon-based sequencing for testing fetal identity and monogenic traits with Single Circulating Trophoblast (SCT) as one form of cell-based NIPT.” PLoSOne 16.4 (2021): e0249695.

2In rare instances, results may rely on a single cell that is co-sequenced with 1-2 maternal cells, which may reduce fetal fraction to 50% or 33%. When this occurs, the report clearly indicates this limitation.

3Unity Confirm and rapid CVS both analyze fetal-derived trophoblast cells. Unity Confirm isolates individual cells via whole genome sequencing (WGS), which is performed on each cell separately, whereas rapid CVS is often performed via FISH. While rapid CVS may analyze more cells, WGS generates more data per cell. In both rapid CVS and fetal cell capture, mosaicism cannot be excluded. Unity Confirm may have false-positive and false-negative results. Results are not a guaranty. Important medical decisions should not rely on UnityConfirm test results alone. Clinical correlation is necessary. Unity Confirm is a laboratory-developed test performed in a CLIA-certified and CAP-accredited laboratory. It is not an FDA-approved or FDA-cleared diagnostic test. Test performance may vary based on gestational age and other factors.

Forward-Looking Statements
This press release contains certain forward-looking statements within the meaning of federal securities laws. These forward-looking statements generally are identified by the words “believe,” “project,” “expect,” “anticipate,” “estimate,” “intend,” “strategy,” “future,” “opportunity,” “plan,” “may,” “should,” “will,” “would,” “will be,” “will continue,” “will likely result,” and similar expressions. Forward-looking statements are predictions, projections and other statements about future events that are based on current expectations and assumptions and, as a result, are subject to risks and uncertainties. Forward-looking statements in this press release include, but are not limited to, statements regarding the clinical effectiveness of Unity Confirm. These statements are based on management’s current expectations, forecasts and assumptions, and actual outcomes and results could differ materially from these statements due to a number of factors, some of which are beyond BillionToOne’s control. These and additional risks and uncertainties could affect BillionToOne’s financial and operating results and cause actual results to differ materially from those indicated by the forward-looking statements made in this press release. These risks and uncertainties include, but are not limited to, the risk that Unity Confirm is not clinically effective and not  adopted by healthcare professionals and those discussed under the captions “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operation” and elsewhere in BillionToOne’s most recently filed Annual Report on Form 10-K, and other filings we make with the Securities and Exchange Commission from time to time. The forward-looking statements in this press release are based on information available to BillionToOne as of the date hereof, and BillionToOne disclaims any obligation to update any forward-looking statements provided to reflect any change in its expectations or any change in events, conditions, or circumstances on which any such statement is based, except as required by law. These forward-looking statements should not be relied upon as representing BillionToOne’s views as of any date subsequent to the date of this press release.

About BillionToOne
Headquartered in Menlo Park, California, BillionToOne is a next-generation molecular diagnostics company with a mission to create powerful and accurate tests that are accessible to all. The company’s patented Quantitative Counting Templates™ (QCT™) molecular counting platform is the only multiplex technology that can accurately count DNA molecules at the single-molecule level. For more information, visit www.billiontoone.com.

Media Contact
billiontoone@moxiegrouppr.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/billiontoone-launches-unity-confirm-a-category-defining-test-that-bridges-the-gap-between-screening-and-invasive-diagnostics-302760412.html

SOURCE BillionToOne

Continue Reading

Technology

2026 Brockton High School Film Festival

Published

on

By

Brockton High School Students Premiere Original Films Exploring Mental Wellness and Leadership

Twenty-three student creators showcase cinematic takes on boundaries, bias, and leadership; selected works to advance to the National SALT 12 Film Festival.

BROCKTON, Mass., May 1, 2026 /PRNewswire-HISPANIC PR WIRE/ — Brockton High School hosted the 2026 Brockton High School Film Festival, a community celebration of student voice and mental wellness. Organized by the nonprofit SALT ED Inc., the event premiered five original short films created by 23 students participating in the “Reel Funny” program.

Unlike traditional film programs, Reel Funny uses media production as a vehicle for personal growth rather than just technical instruction. The program guides students through a series of workshops focused on “soft skills”—including conflict resolution, recognizing internal bias, and establishing healthy personal boundaries. Students are then challenged to apply these lessons by collaborating in groups to write, produce, and edit their own films entirely independently.

A unique and critical component of the Reel Funny process is its integration of mental health professional oversight. Following the students’ film submissions, Eun Joo You, a Licensed Clinical Social Worker (LCSW) with Care Plus New Jersey, conducted a specialized screening of the works. This clinical review serves to evaluate student mental wellness and identify early signs of emotional distress, followed by direct engagement with the students to discuss their creative themes and overall well-being.

“The opportunity for our students to engage in this type of work is paramount to their development as well-rounded individuals,” said Kevin McCaskill, Principal of Brockton High School. “When we talk about preparing the next generation of leaders, we aren’t just talking about academics; we are talking about the emotional intelligence and self-awareness that programs like ‘Reel Funny’ provide. These films are a powerful reflection of their growth.”

The celebration invited friends, families, and local community members to acknowledge the leadership and vulnerability displayed by these young creators.

“This program empowers students to turn self-reflection into a leadership tool,” said Joonho Lee, CEO of Kbean®, a primary supporter of the initiative. “By giving students the autonomy to produce these films on their own terms, we see a level of authenticity that traditional education often misses.”

Looking Ahead: The SALT 12 National Showcase 
The Brockton High School festival serves as a qualifying event for the 3rd Annual SALT 12 Film Festival scheduled for the end of 2026. SALT 12 is a national platform that gathers the most impactful student films from across the country, allowing participants to share their voices with a public audience and compete for national recognition.

For more information about SALT ED Inc., the Reel Funny curriculum, or the upcoming SALT 12 National Showcase, please visit www.salt-ed.org.

About SALT ED Inc.
SALT ED Inc. is a nonprofit organization dedicated to empowering underserved youth through media production, workforce development, and mental wellness initiatives. Their signature “Reel Funny” program helps students develop the emotional intelligence and leadership skills necessary to succeed as next-generation leaders.

Photo – https://mma.prnewswire.com/media/2954869/Picture1.jpg

Logo – https://mma.prnewswire.com/media/1897111/5888831/Kbean_Logo.jpg

SOURCE Kbean

Continue Reading

Technology

Products That Count Announces the Winners of the 2026 CPO Awards, Honoring the Product Leaders Redefining Their Craft in the AI Era

Published

on

By

The annual Awards recognize Chief Product Officers whose scope, influence, and impact have expanded dramatically as AI reshapes every organization.

SAN FRANCISCO, May 1, 2026 /PRNewswire-PRWeb/ — Products That Count, the world’s largest nonprofit community of product managers with over 600,000 members, today announced the winners of the 2026 CPO Awards. The Awards, produced in partnership with Mighty Capital, celebrate the Chief Product Officers whose leadership is shaping how products are built, shipped, and scaled in a moment of unprecedented change.

“The CPO mandate has fundamentally expanded,” said SC Moatti, Founder and Managing Partner of Products That Count. “Our winners this year are setting the standard for what the role becomes when AI is woven into every layer of the business. They are the builders other builders learn from.”

The role of the Chief Product Officer has never been broader. Today’s CPOs are architecting the systems, teams, and decisions that determine whether their companies win in the AI era.

The 2026 CPO Award Winners, by category:

President / CEO: Former CPOs who have elevated to the top role.

Eglae Recchia, CPO, Keyway

Maria Thomas, CEO (promoted from CPO), Rebrandly

Nabil Bukhari, President, Extreme Networks

Shiven Ramji, President & Chief Product Officer, Okta

Investor Mindset: Treating product like a portfolio of bets, with M&A as a strategic lever.

Achuth Rao, CPO, New York Life Insurance Company

Andrew Tsao, CPO & Analytics Officer, Audible

Dane Glasgow, CPO, Paramount/Skydance

Diana Benli, Chief Product Officer, Cognizant

Diego Dugatkin, Chief Product Officer, Box

Mike Bidgoli, CPO & CTO, Tubi

Vasu Murthy, CPO, Cohesity

Vrushali Paunikar, CPO, Carta

Ambrish Verma, Chief Product Officer, Ingram Micro

Enterprise Scale: Operating in complexity. Not speed alone, but transformation at scale.

Carla Guzzetti, Chief Product Officer, Cloud Applications, Extreme Networks

Eddie Garcia, Chief Product Officer, eBay

Gautam Shah, Chief Product Officer, Carelon

Ghazal Badiozamani, SVP of Product Management, Cengage

Kelli Fielding, Chief Product Officer, Europe, TransUnion

Mikhail Vaysbukh, Chief Product Officer, Elsevier

Monica Ugwi, GM, Copilot + Agents for Manufacturing & Mobility, formerly Microsoft

Randall Hounsell, SVP Connected Living Product, Comcast

Rita Khan, Chief Consumer & Digital Officer, formerly Optum

Ryan Bergstrom, Chief Product Officer, Paychex

Tim Simmons, Chief Product Officer, formerly Walmart International

Tina Tarquinio, Chief Product Officer, IBM Z and LinuxONE, IBM

Todd Garner, CPO, Sam’s Club

Trey Courtney, Global Chief Product & Partnerships Officer, Mood Media

Wyatt Jenkins, SVP Product, Intuit

Shayani Roy, SVP Product Management and Design, OpenTable

Scale Up: Growth-stage leaders putting the scale in place.

Aaron Seevers, Chief Product Officer, Noom

Avijit Sinha, SVP Corporate Development, EDB

Hannah Park, Chief Product Officer, Planned Parenthood

Joe Futty, CPO & CTO, Pipedrive

Jonathan Shottan, Chief Product Officer, Tonal

Kimberly Bloomston, CPO, 6sense

Kousthub Raghavan, Chief Product & Digital Officer, CLEAR

Natalia Williams, Chief Product Officer, Qonto

Nikita Miller, Chief Product Officer, Perk

Nilesh Khandelwal, Chief Product Officer, Rakuten Rewards

Paul Burke, CPO, Reveleer

Randhir Vieira, CPO, formerly Healthify

Renn Turiano, CPO, Gannett – USA Today Network

Sarah Turrin, CPO, Color

Emerging: On an amazing trajectory, regardless of tenure.

Adam Kelsey, EVP, Product Management, SignalWire

Apurva Garware, SVP, Head of Product, Invisible Technologies

Chai Atreya, Chief Product Officer, ActiveCampaign

Jack Brody, Chief Product Officer, Suno

John Barrus, VP of Product Management, Niobium

Kevin Swint, former Co-Founder & CPO, RemixAI

Nirmal Kumar, CPO, Aliaswire

Rafael Flores, Chief Product Officer, Treasure Data.ai

Sarah Jacob Singh, CPO & CTO, Medbridge

Sarosh Waghmar, CPO & Co-Founder, Spotnana

Vanessa Davis, CPO, LegalOn

Vikas Seth, CPO, ARIS

Platform: Multiplying impact beyond their own product by leveraging the ecosystem at scale.

Arnab Bose, CPO, Asana

Kishan Chetan, EVP & GM, Agentforce Service Cloud, Salesforce

Shardul Vikram, Chief Product Officer, SAP Application AI, SAP

Tom Occhino, Chief Product Officer, Vercel

Rohit Badlaney, CPO & General Manager, IBM Cloud Platform, IBM

Terre Layton, former CPO, BetterHealth

B.J. Boyle, Chief Product Officer, MacroHealth

Winners were selected by an Independent Advisory Council of seasoned product executives based on impact and leadership.

ABOUT PRODUCTS THAT COUNT

Products That Count is the world’s largest nonprofit community, engaging 600,000+ product managers and Chief Product Officers (CPOs) united by a mission: to empower everyone to build products that truly count. In a world flooded with products, only a few ignite passion, deliver value at scale, and transform lives. Behind those exceptional products are visionary CPOs and high-performing product teams driving innovation at the most bleeding-edge companies. We recognize these trailblazers through our coveted Awards, accelerate careers from PM to the C-suite and beyond through daily best practices, and serve as the trusted advisor to nearly all Fortune 1000 CPOs. Our Corporate Alliance includes Walmart, Ford, Cisco, Johnson & Johnson, Amplitude, and more. The most admired product leaders across industries serve on our Advisory Council, guiding the future of product leadership. Together, we’re shaping a future where every product counts. Learn more at productsthatcount.org

ABOUT MIGHTY CAPITAL

Mighty Capital is the VC firm that leverages the Product Alpha Effect, a data-backed framework for outperformance that proves great products drive great businesses. Founded in 2018 by SC Moatti, a product visionary and former Meta product leader, and Jennifer Vancini, a veteran of tech investing and M&A, we bring a differentiated edge to venture. Through Moatti’s 600,000-strong Products That Count network of product leaders, we see where the world is going before others do. That proprietary signal gives us an advantage in sourcing, diligence, and post-investment value creation. Our portfolio speaks for itself: 1 in 5 companies is a category leader like Amplitude (NASDAQ:AMPL), Groq, and Netskope (NASDAQ:NTSK). Founders consistently call us the most value-add investor on their cap table, and use our global product ecosystem as a marketplace to accelerate time to revenue, scale, and exit. Anchored by GCM Grosvenor, we’re deploying Fund III with both prior funds in top decile DPI and TVPI, more than $20B in value created, and 6 IPOs to date. Learn more at Mighty.Capital.

Media Contact

Emma Shirlin, Products That Count, 1 8287020154, emmashirlin@productsthatcount.com

View original content:https://www.prweb.com/releases/products-that-count-announces-the-winners-of-the-2026-cpo-awards-honoring-the-product-leaders-redefining-their-craft-in-the-ai-era-302759934.html

SOURCE Products That Count

Continue Reading

Trending